163 related articles for article (PubMed ID: 38297203)
1. BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis.
Zakerinasab F; Behfar Q; Parsaee R; Zadeh RH; Foroughi E; Amirbeik A; Ahmadi G
BMC Genom Data; 2024 Jan; 25(1):13. PubMed ID: 38297203
[TBL] [Abstract][Full Text] [Related]
2. Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.
Lee YC; Milne RL; Lheureux S; Friedlander M; McLachlan SA; Martin KL; Bernardini MQ; Smith C; Picken S; Nesci S; Hopper JL; Phillips KA;
Eur J Cancer; 2017 Oct; 84():114-120. PubMed ID: 28802188
[TBL] [Abstract][Full Text] [Related]
3. Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.
Laitman Y; Michaelson-Cohen R; Levi E; Chen-Shtoyerman R; Reish O; Josefsberg Ben-Yehoshua S; Bernstein-Molho R; Keinan-Boker L; Rosengarten O; Silverman BG; Perri T; Korach J; Mor P; Ephrat Ben-Baruch N; Levy Lahad E; Friedman E;
Cancer; 2019 Mar; 125(5):698-703. PubMed ID: 30489631
[TBL] [Abstract][Full Text] [Related]
4. Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis.
Matanes E; Volodarsky-Perel A; Eisenberg N; Rottenstreich M; Yasmeen A; Mitric C; Lau S; Salvador S; Gotlieb WH; Kogan L
J Minim Invasive Gynecol; 2021 May; 28(5):947-956. PubMed ID: 33249269
[TBL] [Abstract][Full Text] [Related]
5. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Oh M; Alkhushaym N; Fallatah S; Althagafi A; Aljadeed R; Alsowaida Y; Jeter J; Martin JR; Babiker HM; McBride A; Abraham I
Prostate; 2019 Jun; 79(8):880-895. PubMed ID: 30900310
[TBL] [Abstract][Full Text] [Related]
6. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
7. BRCA mutations and risk of uterine cancer.
Tanday S
Lancet Oncol; 2016 Aug; 17(8):e324. PubMed ID: 27397041
[No Abstract] [Full Text] [Related]
8. Prevalence of BRCA1 and BRCA2 Mutations Among High-risk Bahraini Patients with Breast Cancer.
Bukamal Z; AlRayes A
Gulf J Oncolog; 2023 May; 1(42):22-25. PubMed ID: 37283256
[TBL] [Abstract][Full Text] [Related]
9. Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers.
McCrorie AD; Ashfield S; Begley A; Mcilmunn C; Morrison PJ; Boyd C; Eccles B; Greville-Heygate S; Copson ER; Cutress RI; Eccles DM; Savage KI; McIntosh SA
J Pathol Clin Res; 2020 Apr; 6(2):146-153. PubMed ID: 32022473
[TBL] [Abstract][Full Text] [Related]
10. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
Clin Cancer Res; 2015 Jan; 21(1):211-20. PubMed ID: 25348513
[TBL] [Abstract][Full Text] [Related]
11.
Kharel S; Shrestha S; Yadav S; Shakya P; Baidya S; Hirachan S
J Int Med Res; 2022 Jan; 50(1):3000605211070757. PubMed ID: 35000471
[TBL] [Abstract][Full Text] [Related]
12. Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.
Wang F; Fang Q; Ge Z; Yu N; Xu S; Fan X
Mol Biol Rep; 2012 Mar; 39(3):2109-18. PubMed ID: 21643751
[TBL] [Abstract][Full Text] [Related]
13. The preventive effect of breastfeeding against ovarian cancer in BRCA1 and BRCA2 mutation carriers: A systematic review and meta-analysis.
Eoh KJ; Park EY; Chang YJ; Ha HI; Hong J; Huang D; Nam EJ; Lim MC
Gynecol Oncol; 2021 Oct; 163(1):142-147. PubMed ID: 34304906
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
Oh M; McBride A; Yun S; Bhattacharjee S; Slack M; Martin JR; Jeter J; Abraham I
J Natl Cancer Inst; 2018 Nov; 110(11):1178-1189. PubMed ID: 30380096
[TBL] [Abstract][Full Text] [Related]
15. Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis.
Wang Y; Song Z; Zhang S; Wang X; Li P
Eur J Surg Oncol; 2022 Jun; 48(6):1209-1216. PubMed ID: 35216860
[TBL] [Abstract][Full Text] [Related]
16. Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis.
Nahshon C; Segev Y; Gemer O; Bar Noy T; Schmidt M; Ostrovsky L; Lavie O
Gynecol Oncol; 2021 Mar; 160(3):755-762. PubMed ID: 33309051
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations].
Duan RR; Sun LX; Zhao HW
Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292
[No Abstract] [Full Text] [Related]
18. BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.
El Saghir NS; Zgheib NK; Assi HA; Khoury KE; Bidet Y; Jaber SM; Charara RN; Farhat RA; Kreidieh FY; Decousus S; Romero P; Nemer GM; Salem Z; Shamseddine A; Tfayli A; Abbas J; Jamali F; Seoud M; Armstrong DK; Bignon YJ; Uhrhammer N
Oncologist; 2015 Apr; 20(4):357-64. PubMed ID: 25777348
[TBL] [Abstract][Full Text] [Related]
19. Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
Golan T; Raitses-Gurevich M; Kelley RK; Bocobo AG; Borgida A; Shroff RT; Holter S; Gallinger S; Ahn DH; Aderka D; Apurva J; Bekaii-Saab T; Friedman E; Javle M
Oncologist; 2017 Jul; 22(7):804-810. PubMed ID: 28487467
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis.
Abdulrashid K; AlHussaini N; Ahmed W; Thalib L
BMC Cancer; 2019 Mar; 19(1):256. PubMed ID: 30898109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]